Skip to main content
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 2007 Aug 13;51(11):4177–4180. doi: 10.1128/AAC.00603-07

Comparative Analysis of IncHI2 Plasmids Carrying blaCTX-M-2 or blaCTX-M-9 from Escherichia coli and Salmonella enterica Strains Isolated from Poultry and Humans

Aurora García Fernández 1, Axel Cloeckaert 2,*, Alessia Bertini 1, Karine Praud 2, Benoît Doublet 2, François-Xavier Weill 3, Alessandra Carattoli 1
PMCID: PMC2151457  PMID: 17698627

Abstract

Salmonella enterica blaCTX-M-2 and blaCTX-M-9 plasmid backbones from isolates from Belgium and France were analyzed. The blaCTX-M-2-plasmids from both human and poultry isolates were related to the IncHI2 pAPEC-O1-R plasmid, previously identified in the United States in avian Escherichia coli strains; the blaCTX-M-9 plasmids were closely related to the IncHI2 R478 plasmid.


The plasmid-encoded CTX-M family have recently become dominant extended-spectrum β-lactamases (ESBLs) in human isolates in Europe (13). Significantly, the CTX-M enzymes have emerged in isolates of Escherichia coli and Salmonella spp. from food, companion, and wild animals, raising a potential public health concern (1, 2, 4, 6, 12, 14-16).

In Belgium and France, Salmonella enterica serovar Virchow producing the CTX-M-2 ESBL was firstly identified in poultry flocks, then in poultry meat, and subsequently in humans over the period 2000 to 2003 (3). The chronology of isolation of these strains suggested that these bacteria were transmitted to humans via the food chain, specifically by poultry meat. In French Guiana in 2004, a Salmonella enterica serovar Typhimurium strain producing CTX-M-2 was isolated from a patient with gastroenteritis. In France in 2002, one CTX-M-9-producing S. enterica rough strain was isolated from a patient, and in 2003, S. enterica serovar Virchow strains were isolated from poultry (17).

The objective of this study was to characterize plasmids carrying blaCTX-M-2 and blaCTX-M-9 from poultry sources and to compare them with those circulating in humans. CTX-M-positive transconjugants were obtained in E. coli K-12 from CTX-M-2 or CTX-M-9 producers. The following transconjugates were selected for this study: six from the S. enterica serovar Virchow strain of animal origin, one from the rough isolate, and one from the S. enterica serovar Typhimurium strain (Table 1). The parental strains of these transconjugants were representative of CTX-M-2 or -9 producers for country of isolation, source, pulsed-field gel electrophoresis patterns, and resistance profiles, as previously determined (3, 17). The blaCTX-M-9 integrons in these strains were previously characterized, and gene cassette arrays are reported in Table 1 (17). To determine the structure of the blaCTX-M-2-carrying integrons, the 8,690-bp and 9,017-bp fragments were amplified and fully sequenced from the plasmids of the S. enterica serovar Virchow p1639-SA-00-1 and S. enterica serovar Typhimurium p04-9275-1 strains, respectively. Sequencing results indicate that the integron in S. enterica serovar Virchow was 99% identical to the CTX-M-2 integron found in the E. coli strain of human origin identified in France in 2006 (7) carrying the dfrA1 and aadA1 gene cassettes (deposited in GenBank under accession no. EF592570). The integron from the S. enterica serovar Typhimurium strain showed a different variable region, including the dfrA12, orfF, and aadA2 gene cassettes (Table 1 [deposited in GenBank under accession no. EF592571]).

TABLE 1.

Plasmid backbone analysis of the IncHI2 plasmids in transconjugants obtained from Salmonella and Escherichia coli CTX-M-2 and CTX-M-9 producers

Plasmid (ESBL) Parental strain (source) Country (yr) HI2 replicon type PCR result for:
Reference
smr10-11 smr17-18 smr207-208 smr239-240 O1R_160 terF arsB smr201 smr92-93 smr136 tnsD Integron-borne gene cassettes
p1639-SA-00-1 (CTX-M-2) S. enterica serovar Virchow (poultry) Belgium (2000) HI2-pAPEC-O1-R + + + + + + dfrA1-aadA1 This study
p142-SA-01-1 (CTX-M-2) S. enterica serovar Virchow (poultry) Belgium (2001) HI2-pAPEC-O1-R + + + + + + dfrA1-aadA1 This study
p03-1902-1 (CTX-M-2) S. enterica serovar Virchow (poultry product) Belgium (2003) HI2-pAPEC-O1-R + + + + + + dfrA1-aadA1 This study
p04-9275-1 (CTX-M-2) S. enterica serovar Typhimurium (human feces) French Guiana (2004) HI2-pAPEC-O1-R + + + + + + drfA12-orfF-aadA2 This study
pROU-1 (CTX-M-9) S. enterica rough (human feces) France (2002) HI2-R478 + + + + + + + + + dfrA16-aadA2 This study, 17
p2437-1 (CTX-M-9) S. enterica serovar Virchow (chicken feces) France (2003) HI2-R478 + + + + + + + + + dfrA16-aadA2 This study, 17
p2731-1 (CTX-M-9) S. enterica serovar Virchow (retail chicken meat) France (2003) HI2-R478 + + + + + + + + + dfrA16-aadA2 This study, 17
p3464b-1 (CTX-M-9) S. enterica serovar Virchow (chicken environment) France (2003) HI2-R478 + + + + + + + + + dfrA16-aadA2 This study, 17
112-D-T (CTX-M-9) S. enterica serovar Virchow (human feces) Spain (2000) HI2-R478 + + + + + + + + + dfrA16-aadA2 8, 9
1185-D-T (CTX-M-9) E. coli (human feces) Spain (1998) HI2-R478 + + + + + + + + + dfrA16-aadA2 8, 9
1406-D-T (CTX-M-9) E. coli (human feces) Spain (1999) HI2-R478 + + + + + + + + + dfrA16-aadA2 8, 9
R478a HI2-R478 + + + + + + + + + + 10
pAPEC-01-Rb HI2-pAPEC-O1-R + + + + + + aadA1 11
a

Expected PCR result based on the R478 sequence (EMBL accession no. BX664015).

b

Expected PCR result based on the pAPEC-O1-R sequence (EMBL accession no. DQ517526).

Plasmids carrying blaCTX-M-2 or blaCTX-M-9 were analyzed by PCR-based replicon typing (PBRT) (5): PBRT indicates that all the strains were positive for the HI2 replicon, thus suggesting the presence of common IncHI2 plasmids in these strains. The HI2 replicon was previously detected on CTX-M-9-positive Salmonella and E. coli strains of human origin from Spain (8, 9). Three transconjugants obtained from representative strains of the Spanish collection (one from an S. enterica serovar Virchow strain and two from E. coli) were also included in this study for comparison (Table 1).

The HI2 amplicon was sequenced to confirm the PBRT result, and two types of DNA sequences were observed: the R478 type, showing 100% identity with the HI2 replicon of the reference plasmid R478 isolated from Serratia marcescens in the United States in 1969 (10); and the HI2-APEC-O1-R type, showing 100% homology with the HI2 replicon of the pAPEC-O1-R plasmid, recently described in avian pathogenic E. coli strains in the United States (11). HI2-R478 and HI2-pAPEC-O1-R differ by 29 nucleotide substitutions located within the cis-repeats (iterons) flanking the replicase (repA) gene (accession no. BX664015 and DQ517526, respectively).

Interestingly, the HI2-R478 replicon type was identified in plasmids carrying the blaCTX-M-9 gene, while the HI2-pAPEC-O1-R replicon type was identified in plasmids carrying the blaCTX-M-2 gene (Table 1).

R478 and pAPEC-O1-R plasmids show many common regions, including the previously mentioned HI2 replicon, but also the Tra1 and Tra2 transfer regions and the genes coding for copper, silver, and tellurite resistance (10, 11). The two plasmids diverge in terms of insertion sequences, the presence or absence of a class 1 integron, the Tn10 transposon, and arsenic and mercury resistance loci (11).

To further characterize the CTX-M-2 and CTX-M-9 IncHI2 plasmid backbones, we used a PCR-based scheme, previously applied to the CTX-M-9 producers isolated in Spain (Table 2) (9). This scheme recognizes five DNA targets unique for IncHI2 plasmids and common between R478 and pAPEC (smr10-11, smr17-18, smr207-208, smr239-240 and terF) and five DNA targets that are specific for R478 but negative in pAPEC (smr201, smr92-93, smr136, tnsD, and arsB). An additional PCR is also included here to recognize the O1R_160 gene of pAPEC that is interrupted by a Tn10 insertion in R478 (Table 2). Testing the transconjugants listed in Table 1, we observed that the O1R_160 gene was present in all of the strains, while the smr136 and tnsD genes were absent: these results indicate that both the Tn10 and Tn7 transposons are missing in the CTX-M-2 and -9 plasmids analyzed in this study.

TABLE 2.

Primers used in the plasmid backbone analysisa

Primer pair Product of target gene in R478b Primer sequence PCR gene name (position of amplicon in R478b sequence)
10Fw HtdV, putative membrane protein 5′-AATCGCCTGAATCAGCTGG-3′ smr10-11 (6655-7713)
11Rv HtdT, putative plasmid transfer protein 5′-TTCTTTACTACACCAGAGCC-3′
17Fw SMR0017, putative lipoprotein 5′-AACTCTTGAAAATCGTGG-3′ smr17-18 (18211-19101)
18Rv 5′-CTTCAGGCTATCGTTTCG-3′
TerFw Tellurium resistance protein 5′-ATGCAGGCTCAAGGAATCGC-3′ terF (80270-81163)
TerRv 5′-TTCATCGATCCACGGTCTG-3′
92Fw SMR0092, hypothetical protein 5′-CTATGTAAGCAATGATCCTC-3′ smr92-93 (88861-89862)
93Rv SMR0093, putative inner membrane protein 5′-TATAGAGAGCACCGAAGG-3′
TnsDAFw Tn7-like transposition protein 5′-AATCCTTGTTCAGCCGG-3′ tnsD (119360-120825)
TnsDARv 5′-CAAAAGCCAGCCATGCCC-3′
136Afw SMR0136, hypothetical protein 5′-TACGAAAATGAATTGTGGC-3′ smr136 (120906-121768)
136Arv 5′-AATTTACAATCTGCAGCCC-3′
ArsBFw Arsenical pump membrane protein 5′-AGTGAAAGACAGACGAAGCG-3′ arsB (159735-160870)
ArsBRv 5′-GGCAGATAGTGTGGAATGCG-3′
201Fw SMR0201 hypothetical protein 5′-TGTCAGGCTAAGTCACTGG-3′ smr201 (180398-181466)
201Rv 5′-ATTATACGGTAGATCC-3′
207Fw SMR0207, conserved hypothetical protein 5′-TTTCCCAAATAGGCGACGC-3′ smr207-208 (190238-191131)
208Rv SMR0208, hypothetical protein 5′-ATGTGAAATTACTATACCGG-3′
239Fw SMR0239, hypothetical protein 5′-TGGAACGCGTGGTATGTGG-3′ smr239-240 (219372-220364)
240Rv SMR0240, hypothetical protein 5′-ATACCTGCCGTTTACCC-3′
O1R_160Fw O1R_160, Tn10 insertion site 5′-TTATGATGCTGGGCGTACC-3′ O1R_160 (202719-212075)c
O1R_160Rv 5′-CACCATTACAATCACCTCC-3′
a

The DNA from the reference plasmid R478 of the incompatibility group IncHI2 was used as control for PCR assays. Amplification conditions were initial denaturation at 94°C for 5 min and 30 cycles at 94°C for 1 min, annealing at 60°C for 30 s, and elongation at 72°C for 1 min.

b

EMBL accession no. BX664015.

c

Positions 183121 to 182957 in EMBL accession no. DQ517526.

All of the plasmids were also positive for the five targets recognizing both R478 and pAPEC plasmids, while the blaCTX-M-2-carrying plasmids were negative for the arsB, smr92, and smr201 targets, which were positively detected in the blaCTX-M-9-carrying plasmids (Table 1). These results provided evidence that the blaCTX-M-2 and blaCTX-M-9 plasmids show different plasmid scaffolds despite belonging to the same IncHI2 family: the CTX-M-2 producers from both human and poultry sources are associated with pAPEC-O1-R derivative plasmids, while the CTX-M-9 producers are associated with R478 derivative plasmids. The association between blaCTX-M-9 and R478 was previously demonstrated for E. coli and S. enterica CTX-M-2 and -9 producers isolated in Spain (9). However, this is the first description of CTX-M-9-R478 derivative plasmids in animal sources.

This is also the first description of pAPEC-O1-R derivative plasmids carrying the blaCTX-M-2 gene. It is of concern that the pAPEC-O1-R plasmid, largely prevalent in avian pathogenic and commensal E. coli strains in the United States (11), is detected with the blaCTX-M-2 gene in Salmonella strains of human and animal origins in Europe.

Contamination with ESBL-producing strains of S. enterica has been extensively suggested to occur through the food chain, but very few Salmonella ESBL producers of animal origin have been reported, while these enzymes are frequently detected in human isolates. In this study, plasmid-mediated horizontal transfer of blaCTX-M-2 and blaCTX-M-9 genes has been demonstrated between poultry and human S. enterica and E. coli strains isolated in very different geographical regions. This result is of major concern because food animals may represent a large reservoir for a further dissemination of such genetic determinants to human pathogens.

Acknowledgments

This work was supported by the MED-VET-NET Contract with the European Commission (FOOD-CT-2004-506122) and the Specific Targeted Research Project “Role of mobile genetic element in the spread of antimicrobial drug resistance” (contract no. LSHM-CT-2005-018705).

Footnotes

Published ahead of print on 13 August 2007.

REFERENCES

  • 1.Abdalhamid, B., J. D. Pitout, E. S. Moland, and N. D. Hanson. 2004. Community-onset disease caused by Citrobacter freundii producing a novel CTX-M β-lactamase, CTX-M-30, in Canada. Antimicrob. Agents Chemother. 48:4435-4437. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Archambault, M., P. Petrov, R. S. Hendriksen, G. Asseva, A. Bangtrakulnonth, H. Hasman, and F. M. Aarestrup. 2006. Molecular characterization and occurrence of extended-spectrum beta-lactamase resistance genes among Salmonella enterica serovar Corvallis from Thailand, Bulgaria, and Denmark. Microb. Drug Resist. 12:192-198. [DOI] [PubMed] [Google Scholar]
  • 3.Bertrand, S., F.-X. Weill, A. Cloeckaert, M. Vrints, E. Mairiaux, K. Praud, K. Dierick, C. Wildemauve, C. Godard, P. Butaye, H. Imberechts, P. A. D. Grimont, and J. M. Collard. 2006. Clonal emergence of extended-spectrum β-lactamase (CTX-M-2)-producing Salmonella enterica serovar Virchow isolates with reduced susceptibilities to ciprofloxacin among poultry and humans in Belgium and France (2000 to 2003). J. Clin. Microbiol. 44:2897-2903. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Boyd, D. A., S. Tyler, S. Christianson, A. McGeer, M. P. Muller, B. M. Willey, E. Bryce, M. Gardam, P. Nordmann, M. R. Mulvey, and the Canadian Nosocomial Infection Surveillance Program, Health Canada. 2004. Complete nucleotide sequence of a 92-kilobase plasmid harboring the CTX-M-15 extended-spectrum beta-lactamase involved in an outbreak in long-term-care facilities in Toronto, Canada. Antimicrob. Agents Chemother. 48:3758-3764. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Carattoli, A., A. Bertini, L. Villa, V. Falbo, K. L. Hopkins, and E. J. Threlfall. 2005. Identification of plasmids by PCR-based replicon typing. J. Microbiol. Methods 63:219-228. [DOI] [PubMed] [Google Scholar]
  • 6.Costa, D., P. Poeta, Y. Saenz, L. Vinue, B. Rojo-Bezares, A. Jouini, M. Zarazaga, J. Rodrigues, and C. Torres. 2006. Detection of Escherichia coli harbouring extended-spectrum beta-lactamases of the CTX-M, TEM and SHV classes in faecal samples of wild animals in Portugal. J. Antimicrob. Chemother. 58:1311-1312. [DOI] [PubMed] [Google Scholar]
  • 7.Eckert, C., V. Gautier, and G. Arlet. 2006. DNA sequence analysis of the genetic environment of various blaCTX-M genes. J. Antimicrob. Chemother. 57:14-23. [DOI] [PubMed] [Google Scholar]
  • 8.García, A., F. Navarro, E. Miró, B. Mirelis, S. Campoy, and P. Coll. 2005. Characterization of the highly variable region surrounding the blaCTX-M-9 gene in non-related Escherichia coli from Barcelona. J. Antimicrob. Chemother. 56:819-826. [DOI] [PubMed] [Google Scholar]
  • 9.García, A., F. Navarro, E. Miró, L. Villa, B. Mirelis, P. Coll, and A. Carattoli. 2007. Acquisition and diffusion of blaCTX-M-9 gene by R478-IncHI2 derivative plasmids. FEMS Microbiol. Lett. 271:71-77. [DOI] [PubMed] [Google Scholar]
  • 10.Gilmour, M. W., N. R. Thomson, M. Sanders, J. Parkhill, and D. E. Taylor. 2004. The complete nucleotide sequence of the resistance plasmid R478: defining the backbone components of incompatibility group H conjugative plasmids through comparative genomics. Plasmid 52:182-202. [DOI] [PubMed] [Google Scholar]
  • 11.Johnson, T. J., Y. M. Wannemeuhler, J. A. Scaccianoce, S. J. Johnson, and L. K. Nolan. 2006. Complete DNA sequence, comparative genomics, and prevalence of an IncHI2 plasmid occurring among extraintestinal pathogenic Escherichia coli isolates. Antimicrob. Agents Chemother. 50:3929-3933. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Liebana, E., M. Batchelor, K. L. Hopkins, F. A. Clifton-Hadley, C. J. Teale, A. Foster, L. Barker, E. J. Threlfall, and R. H. Davies. 2006. Longitudinal farm study of extended-spectrum β-lactamase-mediated resistance. J. Clin. Microbiol. 44:1630-1634. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Livermore, D. M., R. Canton, M. Gniadkowski, P. Nordmann, G. M. Rossolini, G. Arlet, J. Ayala, T. M. Coque, I. Kern-Zdanowicz, F. Luzzaro, L. Poirel, and N. Woodford. 2007. CTX-M: changing the face of ESBLs in Europe. J. Antimicrob. Chemother. 59:165-174. [DOI] [PubMed] [Google Scholar]
  • 14.Meunier, D., E. Jouy, C. Lazizzera, M. Kobisch, and J. Y. Madec. 2006. CTX-M-1- and CTX-M-15-type beta-lactamases in clinical Escherichia coli isolates recovered from food-producing animals in France. Int. J. Antimicrob. Agents 28:402-407. [DOI] [PubMed] [Google Scholar]
  • 15.Pitout, J. D., P. Nordmann, K. B. Laupland, and L. Poirel. 2005. Emergence of Enterobacteriaceae producing extended-spectrum beta-lactamases (ESBLs) in the community. J. Antimicrob. Chemother. 56:52-59. [DOI] [PubMed] [Google Scholar]
  • 16.Teale, C. J., L. Barker, A. P. Foster, E. Liebana, M. Batchelor, D. M. Livermore, and E. J. Threlfall. 2005. Extended-spectrum beta-lactamase detected in E. coli recovered from calves in Wales. Vet. Rec. 156:186-187. [PubMed] [Google Scholar]
  • 17.Weill, F.-X., R. Lailler, K. Praud, A. Kerouanton, L. Fabre, A. Brisabois, P. A. D. Grimont, and A. Cloeckaert. 2004. Emergence of extended-spectrum-β-lactamase (CTX-M-9)-producing multiresistant strains of Salmonella enterica serotype Virchow in poultry and humans in France. J. Clin. Microbiol. 42:5767-5773. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES